76075-103 : Kyprolis 10 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
| NDC: | 76075-103 |
| Labeler: | Onyx Pharmaceuticals, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Kyprolis |
| Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
| Application #: | NDA202714 |
| Rev. Date: |
NDC Package Codes:
- 76075-103-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (76075‑103‑01) > 10 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Carfilzomib
Dosage Strength:
- 10 mg/5mL
Pharmaceutical Classes:
- Proteasome Inhibitor [EPC]
- Proteasome Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 76075-101 Kyprolis 60 mg/30ml Intravenous Injection, Powder, Lyophilized, for Solution by Onyx Pharmaceuticals, Inc.
- 76075-102 Kyprolis 30 mg/15ml Intravenous Injection, Powder, Lyophilized, for Solution by Onyx Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 76075-102Next: 76077-100 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.